Autres langues ImpediMed Limited

Actions

Marché Fermé - Australian S.E. Autres places de cotation 08:10:04 21/05/2024			Varia. 5j.	Varia. 1 janv.
0,085 ^AUD	-5,56 %		+6,25 %	-41,38 %

30/04	Le chiffre d'affaires trimestriel d'ImpediMed augmente au troisième trimestre fiscal ; les actions chutent de 8%.	MT
30/04	Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024

Ord Minnett rates IPD as Speculaitve Buy	01/05
Morgans rates IPD as Speculative Buy	01/05
ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8%	30/04
Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant	17/04
ImpediMed to Present Chronic Breast Cancer-Related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting	11/04
ImpediMed Limited(ASX:IPD) added to S&P/ASX All Ordinaries Index	18/03
Impedimed Names Independent Non-Executive Chair	27/02
ImpediMed Narrows Loss in Fiscal H1, Revenue Declines; Shares Fall 7%	27/02
ImpediMed Limited Reports Earnings Results for the Half Year Ended December 31, 2023	26/02
ImpediMed Says New Guidelines for Lymphedema Detection Will Help Company Sales	14/02
ImpediMed CEO, CFO Step Down; Shares Fall 11%	20/11
ImpediMed Limited Announces CEO Changes	19/11
ImpediMed Limited Announces CFO Changes	19/11
ImpediMed Limited Announces Management Changes	19/11
ImpediMed Secures Payor Clearance for Spectroscopy Device in the US; Shares Rise 4%	03/11
Morgans rates IPD as Add	01/11
ImpediMed Limited Announces Resignation of Mrs. Janet West AM as Non-Executive Director	03/10/23
Impedimed Limited Announces Board Changes	28/09/23
Declaration of Voting Results by ImpediMed Limited	28/09/23
ImpediMed Appoints Medical Chief; Shares Down 3%	27/09/23

Aucun résultat pour cette recherche